CA2350062A1 - Combinations comprising a beta-agonist and a further antidiabetic agent - Google Patents

Combinations comprising a beta-agonist and a further antidiabetic agent Download PDF

Info

Publication number
CA2350062A1
CA2350062A1 CA002350062A CA2350062A CA2350062A1 CA 2350062 A1 CA2350062 A1 CA 2350062A1 CA 002350062 A CA002350062 A CA 002350062A CA 2350062 A CA2350062 A CA 2350062A CA 2350062 A1 CA2350062 A1 CA 2350062A1
Authority
CA
Canada
Prior art keywords
yloxy
insulin
antidiabetic agent
carbazol
ethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002350062A
Other languages
English (en)
French (fr)
Inventor
Jonathan Robert Sanders Arch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Application filed by Individual filed Critical Individual
Publication of CA2350062A1 publication Critical patent/CA2350062A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CA002350062A 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent Abandoned CA2350062A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GB9824791.9 1998-11-11
GB9824790.1 1998-11-11
GB9824789.3 1998-11-11
PCT/GB1999/003755 WO2000027434A1 (en) 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent

Publications (1)

Publication Number Publication Date
CA2350062A1 true CA2350062A1 (en) 2000-05-18

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002350062A Abandoned CA2350062A1 (en) 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent

Country Status (15)

Country Link
EP (1) EP1128845A1 (ko)
JP (1) JP2002529430A (ko)
KR (1) KR20010075698A (ko)
CN (1) CN1332638A (ko)
AU (1) AU766928B2 (ko)
BR (1) BR9915214A (ko)
CA (1) CA2350062A1 (ko)
CZ (1) CZ20011655A3 (ko)
HK (1) HK1041201A1 (ko)
HU (1) HUP0104388A3 (ko)
IL (1) IL143004A0 (ko)
NO (1) NO20012300L (ko)
PL (1) PL348154A1 (ko)
TR (1) TR200101336T2 (ko)
WO (1) WO2000027434A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK8902002A3 (en) 1999-12-23 2002-11-06 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
AU2382601A (en) * 1999-12-24 2001-07-09 Smithkline Beecham Plc Novel method of treatment
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
WO2001083453A1 (fr) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Nouveaux composes tricycliques substitues
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0514452T4 (da) * 1990-02-09 2000-09-18 Upjohn Co Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
AU715233B2 (en) * 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same

Also Published As

Publication number Publication date
EP1128845A1 (en) 2001-09-05
NO20012300D0 (no) 2001-05-10
IL143004A0 (en) 2002-04-21
NO20012300L (no) 2001-07-03
WO2000027434A1 (en) 2000-05-18
TR200101336T2 (tr) 2001-11-21
HK1041201A1 (zh) 2002-07-05
CZ20011655A3 (cs) 2002-06-12
PL348154A1 (en) 2002-05-06
KR20010075698A (ko) 2001-08-09
HUP0104388A3 (en) 2002-12-28
AU1063400A (en) 2000-05-29
CN1332638A (zh) 2002-01-23
JP2002529430A (ja) 2002-09-10
AU766928B2 (en) 2003-10-23
BR9915214A (pt) 2001-12-18
HUP0104388A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
US7241756B2 (en) Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
US7078397B2 (en) Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
JP2005213273A (ja) チアゾリジンジオン、インスリン分泌促進薬およびジグアニドを用いる糖尿病の治療
US20080058388A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
AU766928B2 (en) Combinations comprising a beta-agonist and a further antidiabetic agent
CA2297133A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20040122060A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
NZ501163A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
US20030073644A1 (en) Combinations comprising a beta-agonist and a further antidiabetic agent
ZA200103792B (en) Combinations comprising a beta-agonist and a further antidiabetic agent.
US20030109561A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
MXPA01004826A (en) Combinations comprising a beta-agonist and a further antidiabetic agent
US20020052324A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Legal Events

Date Code Title Description
FZDE Discontinued